Evidence map›Paper›PMID 37620771›Full record

ArticleBMC cancer2023

Ten-year retrospect of the investigation of proximal limbs metastasis in cancer: a multi-center study on survival outcome, limb function status and surgical procedures analysis.

Chao Zhang, Jun Wang, Haixiao Wu, Yile Lin, Vladimir P Chekhonin, Karl Peltzer, Artem V Bukharov, Andrey D Kaprin, Xu Guo, Zheng Liu

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 3 countries.

Chao Zhang *Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China. drzhangchao@tmu.edu.cn.
Jun Wang *The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China.
Haixiao WuKey Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yile LinThe Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China.
Vladimir P ChekhoninThe Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China.
Karl PeltzerThe Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China.
Artem V BukharovP.A. Hertsen Moscow Oncology Research Center - Branch of Federal State Budgetary Institution National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Moscow, Russia.
Andrey D KaprinDepartment of Oncology, Radiology and Nuclear Medicine, Medical Institute of Peoples' Friendship University of Russia, Moscow, Russian Federation.
Xu GuoThe Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China.
Zheng LiuThe Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China. qianchangguadu77@126.com.
Cangzhou Central Hospital · CNFederal Medical Research Centre for Psychiatry and Narcology · RUHeilongjiang Provincial Hospital · CNMinistry of Health of the Russian Federation · RUP.A. Hertzen Moscow Oncology Research Institute · RUPeoples' Friendship University of Russia · RUSino Biological (China) · CNTianjin Medical University Cancer Institute and Hospital · CNUniversity of the Free State · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of study was to evaluate survival outcome and limb function in cancer patients with proximal limbs metastasis. Associated factors on survival outcome and limb function were identified. The comparative analysis between intramedullary nailing and prosthesis surgery in cancer patients with proximal limb metastasis was performed.

methodsIn this five-center retrospective study, patients diagnosed with limbs metastasis were collected. Descriptive statistics was used and log-rank test was performed to analyze the survival in subgroups. The Cox proportional hazards regression analysis was performed to identify the independent prognostic factors. The Musculoskeletal Tumor Society (MSTS) scoring system was used to evaluate limb function after surgery, and t test or analysis of variance (ANOVA) was utilized in subgroup analysis.

resultsA total of 316 patients with limb metastasis were included with mean age at 61.0 years. The most common primary tumor was breast, followed by renal cancer and lung cancer. The median overall survival was 24.0 months and the 1-, 3- and 5-year survival rates were 86.9%, 34.7% and 6.8%, respectively. Primary tumor type, visceral metastasis and chemotherapy were proved to be the independent prognostic factors. The mean Musculoskeletal Tumor Society (MSTS) score was 20.5, significant difference was observed in subgroup of solitary/multiple bone metastasis, with/without pathological fracture, and type of surgery.

conclusionThe present study concluded that primary tumor type, visceral metastasis and chemotherapy were three factors affecting the survival of patients. Compared with intramedullary nailing, the patients underwent prosthesis surgery showed better limb function, this procedure should be encouraged in patients with indication.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsLung NeoplasmsExtremitiesHumansMiddle AgedRetrospective StudiesFunction evaluationLimb metastasisNeoplasm MetastasisPrognosis

Identifiers

PMID37620771
PMCPMC10463808
OpenAlexW4386136943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.